|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis" u$ n! @; {* j6 i) B7 V( o
was to close its brain research facility in Basel, Switzerland," S' [: l3 {* I9 o6 k- H" P7 o7 J
the story noted that this move closely followed similar cuts! H% L; v# M2 W
by rival pharmaceutical firms. As a report from the European College0 O6 P' j3 P" |9 j- X. i1 g8 P1 U
of Neuropsychopharmacology" D6 I4 @6 t, Y+ z7 S3 R- X
had warned a few months earlier, the
$ [& l8 V/ n; ?( yabandonment of research into new psychiatric drugs by AstraZeneca,
* Z8 J3 D( \2 c( n& W2 X. n3 PGlaxoSmithKline! o7 O9 P8 b% v$ K; X0 |
and others meant that “withdrawal of research
: n7 N4 z. E6 L7 `1 Bresources is a withdrawal of hope for patients and their families”.
' k7 |+ ?4 b6 M1 I
0 p+ D5 |+ z; I+ c; _8 n
|, w3 A' @/ I$ q$ n回复有免费下载链接
2 p2 f( c' s1 `- Z% }- l, O8 `% ?' r4 t
|
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
